Amgen stock has a new earnings date ahead of November 3
Published on 10/30/2026 at 16:08 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSKey dates for Amgen investors
- Amgen will publish third-quarter 2026 results after the U.S. market close on November 3.
- CEO Robert A. Bradway is scheduled to join the 4:30 p.m. Eastern Time conference call.
- The public webcast will remain available for replay for at least 90 days.
Amgen will report its third-quarter 2026 results after the close of U.S. markets on Tuesday, November 3, according to a release carried by FT Company Announcements. The announcement was issued on October 28 and gives investors a defined near-term checkpoint for revenue, earnings and management commentary.
Amgen stock traded at 422.05 euros on Lang & Schwarz at 4:03 p.m. Berlin time on Friday, October 30, 2026. That was 2.18 percent above the 413.03-euro quote recorded at 4:08 p.m. Berlin time on October 29 in the previous report.
What has changed since the last report
The latest development is the confirmed timing of the financial update and investor call. Chairman and Chief Executive Officer Robert A. Bradway and other members of senior management are scheduled to participate at 4:30 p.m. Eastern Time after the results release.
The live audio webcast will be available to investors, media and the general public through Amgen's investor website. The company said the replay will remain available for at least 90 days, extending access beyond the event itself.
The results date places attention on Amgen's operating performance and outlook rather than on a new clinical announcement. Investors will be able to assess management's comments on commercial momentum, development spending and the balance between pipeline investment and profitability.
The real-time quote of Amgen stock provides the continuously updated Berlin reference for the share.
Amgen Inc. stock facts
- Company: Amgen Inc.
- ISIN: US0311621009
- Ticker: AMGN
- Primary exchange: Nasdaq
- Lang & Schwarz price: 422.05 euros at 4:03 p.m. Berlin time on October 30, 2026
- Change versus prior report: 2.18 percent above 413.03 euros on October 29, 2026
- Next results: November 3, 2026, after the U.S. market close
The Nasdaq Composite sets the broader market backdrop for U.S.-listed healthcare shares.
